Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab transition strategies after methotrexate in plaque psoriasis
NL-OMON33158Phase 3Recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ustekinumab and methotrexate, sponsored by Janssen Pharmaceutical. Started Sep 2009; status: recruiting.
02
Drugs
ustekinumabmethotrexate
Beyond the preview
Go deeper on NL-OMON33158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33158.